相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Hypomethylating agents (HMA) for the treatment of acute myeloid leukemia and myelodysplastic syndromes: mechanisms of resistance and novel HMA-based therapies
Julia Stomper et al.
LEUKEMIA (2021)
Genome wide DNA methylation analysis of alveolar capillary dysplasia lung tissue reveals aberrant methylation of genes involved in development including the FOXF1 locus
Evelien Slot et al.
CLINICAL EPIGENETICS (2021)
Genome-wide methylation sequencing identifies progression-related epigenetic drivers in myelodysplastic syndromes
Jing-dong Zhou et al.
CELL DEATH & DISEASE (2020)
Differentially Methylated Regions in Desmoid-Type Fibromatosis: A Comparison Between CTNNB1 S45F and T41A Tumors
Milea J. M. Timbergen et al.
FRONTIERS IN ONCOLOGY (2020)
Relationship between p53 expression and prognosis of myelodysplastic syndrome treated with azacitidine
Satoko Oka et al.
JOURNAL OF HEMATOPATHOLOGY (2020)
Reduced protocadherin17 expression in leukemia stem cells: the clinical and biological effect in acute myeloid leukemia
Zi-jun Xu et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2019)
Epigenetic Deregulation of Protocadherin PCDHGC3 in Pheochromocytomas/Paragangliomas Associated With SDHB Mutations
Cristobal Bernardo-Castineira et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
Discovery of the Oncogenic Parp1, a Target of bcr-abl and a Potential Therapeutic, in mir-181a/PPFIA1 Signaling Pathway
Chunming Gu et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2019)
Genome-wide DNA methylation profiling using the methylation-dependent restriction enzyme LpnPI
Ruben Boers et al.
GENOME RESEARCH (2018)
Epigenetic Modifiers in Myeloid Malignancies: The Role of Histone Deacetylase Inhibitors
Johanna S. Ungerstedt
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Differential expression of human γ-tubulin isotypes during neuronal development and oxidative stress points to a γ-tubulin-2 prosurvival function
Eduarda Draberova et al.
FASEB JOURNAL (2017)
Myelodysplasia in younger adults: outlier or unique molecular entity?
David A. Sallman et al.
HAEMATOLOGICA (2017)
PCDH10 gene inhibits cell proliferation and induces cell apoptosis by inhibiting the PI3K/Akt signaling pathway in hepatocellular carcinoma cells
Mingxin Ye et al.
ONCOLOGY REPORTS (2017)
Epigenetic dysregulation of protocadherins in human disease
Nady El Hajj et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2017)
PCDH8 inhibits glioma cell proliferation by negatively regulating the AKT/GSKβ/β-catenin signaling pathway
Zhenkun Zong et al.
ONCOLOGY LETTERS (2017)
Comprehensive mapping of the effects of azacitidine on DNA methylation, repressive/permissive histone marks and gene expression in primary cells from patients with MDS and MDS-related disease
Magnus Tobiasson et al.
ONCOTARGET (2017)
Myelodysplasia in younger adults: outlier or unique molecular entity?
David A. Sallman et al.
HAEMATOLOGICA (2017)
Aging, hematopoiesis, and the myelodysplastic syndromes
Stephen S. Chung et al.
BLOOD ADVANCES (2017)
Protocadherin 10 inhibits cell proliferation and induces apoptosis via regulation of DEP domain containing 1 in endometrial endometrioid carcinoma
Yihua Yang et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2016)
Protocadherin20 Acts as a Tumor Suppressor Gene: Epigenetic Inactivation in Nasopharyngeal Carcinoma
Tao Chen et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2015)
PCDH10 inhibits cell proliferation of multiple myeloma via the negative regulation of the Wnt/β-catenin/BCL-9 signaling pathway
Yonghui Xu et al.
ONCOLOGY REPORTS (2015)
PCDH20 functions as a tumour-suppressor gene through antagonizing the Wnt/β-catenin signalling pathway in hepatocellular carcinoma
J. Lv et al.
JOURNAL OF VIRAL HEPATITIS (2015)
Nuclear factor-κB is involved in the protocadherin-10-mediated pro-apoptotic effect in multiple myeloma
Zhen Li et al.
MOLECULAR MEDICINE REPORTS (2014)
The incidence of myelodysplastic syndromes in Western Greece is increasing
Christina Avgerinou et al.
ANNALS OF HEMATOLOGY (2013)
Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet
Luca Malcovati et al.
BLOOD (2013)
Clinical and biological implications of driver mutations in myelodysplastic syndromes
Elli Papaemmanuil et al.
BLOOD (2013)
Prognostic Score Including Gene Mutations in Chronic Myelomonocytic Leukemia
Raphael Itzykson et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Protocadherin 17 acts as a tumour suppressor inducing tumour cell apoptosis and autophagy, and is frequently methylated in gastric and colorectal cancers
Xiaotong Hu et al.
JOURNAL OF PATHOLOGY (2013)
Genome-wide methylation profiling in decitabine-treated patients with acute myeloid leukemia
Pearlly Yan et al.
BLOOD (2012)
Long-range epigenetic silencing of chromosome 5q31 protocadherins is involved in early and late stages of colorectal tumorigenesis through modulation of oncogenic pathways
A. R. Dallosso et al.
ONCOGENE (2012)
Role of BCL2L10 methylation and TET2 mutations in higher risk myelodysplastic syndromes treated with 5-Azacytidine
M. T. Voso et al.
LEUKEMIA (2011)
Incidence and prevalence of myelodysplastic syndromes: Data from the Dusseldorf MDS-registry
Judith Neukirchen et al.
LEUKEMIA RESEARCH (2011)
FLT3 and NPM1 mutations in Chinese patients with acute myeloid leukemia and normal cytogenetics
Lei Wang et al.
JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B (2010)
Methylation of Protocadherin 10, a Novel Tumor Suppressor, Is Associated With Poor Prognosis in Patients With Gastric Cancer
Jun Yu et al.
GASTROENTEROLOGY (2009)
KRAB-type zinc-finger protein Apak specifically regulates p53-dependent apoptosis
Chunyan Tian et al.
NATURE CELL BIOLOGY (2009)
Myelodysplastic syndromes - Incidence and survival in the United States
Xiaomei Ma et al.
CANCER (2007)
Functional epigenetics identifies a protocadherin PCDH10 as a candidate tumor suppressor for nasopharyngeal, esophageal and multiple other carcinomas with frequent methylation
J Ying et al.
ONCOGENE (2006)
MDM2 interaction with nuclear corepressor KAP1 contributes to p53 inactivation
CG Wang et al.
EMBO JOURNAL (2005)
Sequence-specific transcriptional corepressor function for BRCA1 through a novel zinc finger protein, ZBRK1
L Zheng et al.
MOLECULAR CELL (2000)